Background
==========

Polyoxypeptin A (PLYA) was isolated from the culture broth of *Streptomyces* sp. MK498-98 F14, along with a deoxy derivative named as polyoxypeptin B (PLYB), as a result of screening microbial culture extracts for apoptosis inducer of the human pancreatic adenocarcinoma AsPC-1 cells that are highly apoptosis-resistant \[[@B1],[@B2]\]. PLYA is composed of an acyl side chain and a cyclic hexadepsipeptide core that features two piperazic acid units (Figure  [1](#F1){ref-type="fig"}). Structurally similar compounds have been identified from actinomycetes including A83586C \[[@B3]\], aurantimycins \[[@B4]\], azinothricin \[[@B5]\], citropeptin \[[@B6]\], diperamycin \[[@B7]\], kettapeptin \[[@B8]\], IC101 \[[@B9]\], L-156,602 \[[@B10]\], pipalamycin \[[@B11]\], and variapeptin \[[@B12]\] (Figure  [1](#F1){ref-type="fig"}). This group of secondary metabolites was named 'azinothricin family' after the identification of azinothricin as the first member in 1986 from *Streptomyces* sp. X-1950.

![Structures of polyoxypeptin A and B, and other natural products of Azinothricin family.](1471-2180-14-30-1){#F1}

The compounds in this family exhibit diverse biological activities, such as potent antibacterial, antitumor \[[@B13],[@B14]\], and anti-inflammatory activities \[[@B15]\], and acceleration of wound healing \[[@B16]\]. Both PLYA and PLYB were confirmed to be potent inducers of apoptosis. They can inhibit the proliferation of apoptosis-resistant AsPC-1 cells with IC~50~ values of 0.062 and 0.015 μg/mL. They can also induce early cell death in human pancreatic adenocarcinoma AsPC-1 cell lines with ED~50~ values of 0.08 and 0.17 μg/mL, more efficiently than adriamycin and vinblastine that can't induce death of AsPC-1 cells even at 30 μg/mL \[[@B2]\]. In addition, they are able to induce apoptotic morphology and internucleosomal DNA fragmentation in AsPC-1 cell lines at low concentrations \[[@B17]\].

Polyoxypeptins (A and B) possess a variety of attractive biosynthetic features in their structures. The C~15~ acyl side chain may present a unique extension unit in polyketide synthase (PKS) assembly line probably derived from isoleucine \[[@B18]\]. The cyclo-depsipeptide core consists of six unusual amino acid residues at high oxidation states, including 3-hydroxyleucine, piperazic acid, N-hydroxyalanine, 5-hydroxypiperazic acid (for PLYA) or piperazic acid (for PLYB), 3-hydroxy - 3-methylproline, and N-hydroxyvaline. The most intriguing is the hydroxylation at α-amino groups of the [l]{.smallcaps}-alanine and [l]{.smallcaps}-valine, different from that at terminal amino group of ornithine or lysine in siderophore biosynthesis \[[@B19]\]. It is worth to note that (*2S*, *3R*) -3-hydroxy - 3-methylproline presents a synthetic challenge \[[@B20]\]. Both structural novelty and biological activity of polyoxypeptins have spurred much interest in understanding the biosynthetic mechanism and employing biosynthesis and combinatorial biosynthesis to create new polyoxypeptin derives.

Here, we report the identification and characterization of the biosynthetic gene cluster for PLYA based on the genome sequencing, bioinformatics analysis, and systematic gene disruptions. The five stand-alone nonribosomal peptide synthetase (NRPS) domains were confirmed to be essential for PLYA biosynthesis, putatively involved in the biosynthesis of the unusual building blocks for assembly of the peptide backbone. Furthermore, three hydroxylases and two P450 enzymes were genetically characterized to be involved in the biosynthesis of PLYA. Among them, the P450 enzyme PlyM may play a role in transforming PLYB to PLYA.

Results and discussion
======================

Identification and analysis of the ply gene cluster
---------------------------------------------------

Whole genome sequencing of *Streptomyces* sp. MK498-98 F14 using the 454 sequencing technology yielded 11,068,848 bp DNA sequence spanning 528 contigs. Based on the structural analysis of PLYs, we hypothesized that PLYs are assembled by a hybrid PKS/NRPS system. Bioinformatics analysis of the whole genome revealed at least 20 NRPS genes and 70 PKS genes. Among them, the contig00355 (48439 bp DNA sequence) attracted our attention because it contains 7 putative NRPS genes and 4 PKS genes encoding total 4 PKS modules that perfectly match the assembly of the C~15~ acyl side chain based on the colinearity hypothesis \[[@B21]\]. Moreover, *orf14777* (*plyP*) annotated as an [l]{.smallcaps}-proline-3-hydroxylase may be involved in the hydroxylation of 3-methylproline, one of the proposed precursor of PLYA \[[@B18]\]. NRPS analysis program revealed that 7 NRPS genes encode a free-standing peptidyl carrier protein (PCP) (PlyQ), 3 stand-alone thioesterase (TE) domains (PlyI, PlyS, and PlyY), and 3 NRPS modules that are not sufficient for assembly of the hexapeptide. Therefore, we continued to find another relevant contig00067 (83207 bp DNA sequence) contains 4 NRPS genes encoding a free-standing adenylation (A) domain (PlyC) and PCP (PlyD), and 3 NRPS modules. Taken together, the total 6 NRPS modules and 4 PKS modules are sufficient for the assembly of PLYs.

To confirm involvement of the genes in these two contigs by disruption of specific NRPS genes, a genomic library of *Streptomyces* sp. MK498-98 F14 was constructed using SuperCos1 \[[@B22]\] and \~3000 clones were obtained. Two pairs of primers (Additional file [1](#S1){ref-type="supplementary-material"}: Table S3) were designed on the base of two hydroxylases (PlyE and PlyP) from the contig00067 and contig00355, respectively, and used to screen the cosmid library using PCR method \[[@B23]\]. 10 positive cosmids derived from the primer of *plyE* and 11 positive cosmids derived from the primer of *plyP* were obtained. Interestingly, these two sets of cosmids overlapped one same cosmid, 15B10, which gave the further evidence that these two contigs belong to the same contig (Figure  [2](#F2){ref-type="fig"}A). Thus, we used 15B10 as a template to fill the gap between these two contigs by PCR sequencing and got a 131,646 bp contiguous DNA sequence (Figure  [2](#F2){ref-type="fig"}A). Subsequently, a NRPS gene *orf14800* (*plyH*) was inactivated by replacement of *plyH* with apramycin resistant gene (*aac(3)IV-oriT*) cassette in the genome of *Streptomyces* sp. MK498-98 F14 (Additional file [1](#S1){ref-type="supplementary-material"}: Scheme S1). The resulting double-crossover mutant completely abolished the production of PLYA (Figure  [3](#F3){ref-type="fig"}, trace i), confirming that the genes in this region are responsible for biosynthesis of PLYs.

![**The biosynthetic gene cluter and proposed biosynthetic pathways for PLYA. A**, Organization of the genes for the biosynthesis of PLYA. Their putative functions were indicated by color-labeling. **B**, the proposed model for PLYA skeleton assembly driven by the hybrid PKS/NRPS system. KS: Ketosynthase; AT: Acyltransferase; ACP: Acyl carrier protein; DH: Dehydratase; KR: Ketoreductase; ER: Enoyl reductase; A: Adenylation domain; PCP: Peptidyl carrier protein; C: Condensation domain; E: Epimerase domain; M: Methyltransferase; TE: Thioesterase. **C**, the proposed pathway for the biosynthesis of **3** (2-(2-methylbutyl)malonyl-ACP). **D**, the biosynthesis of **4** ([l]{.smallcaps}-piperazic acid). **E**, the proposed pathway for the biosynthesis of the building blocks **5** (N-hydroxylvaline) and **6** (N-hydroxylalanine). **F** and **G**, the proposed biosynthetic pathways of the building blocks **7** ((*R*)-3-hydroxy-3-methyproline) and **8** (3-hydroxyleucine).](1471-2180-14-30-2){#F2}

![**Verification of the ply gene cluster.** LC-MS analysis (extracted ion chromatograms of m/z \[M + H\]^+^ 969.5 corresponding to PLYA) of *Streptomyces* sp. MK498-98 F14 wild type (indicated with WT) and mutants (Δ*orf1*, Δ*orf11*, and Δ*plyH*).](1471-2180-14-30-3){#F3}

Bioinformatics analysis suggested that 37 open reading frames (ORFs, Figure  [2](#F2){ref-type="fig"}A and Table  [1](#T1){ref-type="table"}) spanning 75 kb in this region were proposed to constitute the *ply* gene cluster based on the functional assignment of the deduced gene products. Among them, 4 modular type I PKS genes (*plyTUVW*) and 4 modular NRPS genes (*plyXFGH*) encoding 4 PKS modules and 6 NRPS modules are present for the assembly of the PLY core structure (Figure  [2](#F2){ref-type="fig"}B). Other 6 NRPS genes (*plyCDQISY*) encode an A domain, two PCPs, and three TEs that are free-standing from the modular NRPSs. They are suggested to be involved in the biosynthesis of nonproteinogenic amino acid building blocks. 6 genes (*orf5-orf10*) are proposed to be involved in the biosynthesis of a novel extender unit for PKS assembly (Figure  [2](#F2){ref-type="fig"}C). There are 6 genes (*orf4* and *plyEMOPR*) encoding putative hydroxylases or oxygenases that are proposed to responsible for the biosynthesis of unusual building blocks or post-modifications (Figure  [2](#F2){ref-type="fig"}D-G). There are 2 ABC transporter genes (*plyJ* and *plyK*) and 4 putative regulatory genes (*orf2*, *plyB*, *plyL*, and *plyZ*). In addition, an aminotransferase gene (*plyN*) is located in the center of the *ply* gene cluster that is probably involved in the biosynthesis of the novel PKS extender unit (**3**) (Figure  [2](#F2){ref-type="fig"}C).

###### 

Deduced functions of ORFs in the biosynthetic gene cluster of PLYA

  **Gene**     **Size**^**a**^   **Accession no.**   **Proposed function**                             **Homologous protein species**          **Identity/Similarity**
  ------------ ----------------- ------------------- ------------------------------------------------- --------------------------------------- -------------------------
  *orf03399*   384               YP_003099796        Nucleotidyl transferase                           Actinosynnema mirum DSM 43827           64/73
  *orf03396*   309               YP_004903951        putative sugar kinase                             Kitasatospora setae KM-6054             50/62
  *orf1*       422               YP_003099794        3-dehydroquinate synthase                         Actinosynnema mirum DSM 43827           56/69
  *orf2*       128               EID72461            MarR family transcriptional regulator             Rhodococcus imtechensis RKJ300          71/83
  *orf3*       146               ZP_09957194         Hypothetical protein                              Streptomyces chartreusis NRRL 12338     75/84
  *orf4*       566               CAJ61212            Putative polyketide oxygenase/hydroxylase         Frankia alni ACN14a                     77/83
  *orf5*       377               ZP_04706918         Alcohol dehydrogenase BadC                        Streptomyces roseosporus NRRL 11379     76/86
  *orf6*       312               ZP_06582592         3-oxoacyl-\[acyl-carrier-protein\] synthase III   Streptomyces roseosporus NRRL 15998     71/82
  *orf7*       82                ZP_04706920         Hypothetical protein                              Streptomyces roseosporus NRRL 11379     59/75
  *orf8*       82                ZP_04706921         Dihydrolipoamide succinyltransferase              Streptomyces roseosporus NRRL 11379     65/81
  *orf9*       326               ZP_06582595         2-oxoisovalerate dehydrogenase                    Streptomyces roseosporus NRRL 15998     75/87
  *orf10*      303               ZP_04706923         Pyruvate dehydrogenase                            Streptomyces roseosporus NRRL 11379     74/84
  *plyA*       71                YP_640626           MbtH-like protein                                 Mycobacterium sp. MCS                   80/87
  *plyB*       225               YP_712760           Putative regulator                                Frankia alni ACN14a                     76/84
  *plyC*       528               YP_712761           A                                                 Frankia alni ACN14a                     77/85
  *plyD*       77                YP_712762           PCP                                               Frankia alni ACN14a                     85/94
  *plyE*       395               YP_712763           Putative hydroxylase                              Frankia alni ACN14a                     76/86
  *plyF*       2583              ABV56588            C-A-PCP-E-C-A-PCP                                 Kutzneria sp. 744                       56/68
  *plyG*       2809              ZP_05519638         C-A-PCP-E-C-A-PCP                                 Streptomyces hygroscopicus ATCC 53653   73/82
  *plyH*       1662              BAH04161            C-A-M-PCP-TE                                      Streptomyces triostinicus               72/82
  *plyI*       247               YP_712767           TE                                                Frankia alni ACN14a                     80/87
  *plyJ*       312               YP_003112824        Daunorubicin resistance ABC transporter           Catenulispora acidiphila DSM 44928      78/90
  *plyK*       253               YP_712769           ABC transporter system                            Frankia alni ACN14a                     71/81
  *plyL*       1043              YP_003112826        Transcriptional regulator                         Catenulispora acidiphila DSM 44928      72/80
  *plyM*       412               AAT45271            Cytochrome P450 monooxygenase                     Streptomyces tubercidicus               43/59
  *plyN*       450               ZP_04604097         Aminotransferase class I and II                   Micromonospora sp. ATCC 39149           58/70
  *plyO*       308               ZP_03862696         Polyketide fumonisin                              Kribbella flavida DSM 17836             48/64
  *plyP*       270               ZP_04292518         L-proline 3-hydroxylase type II                   Bacillus cereus R309803                 32/51
  *plyQ*       88                YP_712776           PCP                                               Frankia alni ACN14a                     76/89
  *plyR*       415               YP_712777           Cytochrome P450 monooxygenase                     Frankia alni ACN14a                     77/85
  *plyS*       245               AAT45287            TE                                                Streptomyces tubercidicus               70/81
  *plyT*       1031              YP_712779           KS-AT-ACP                                         Frankia alni ACN14a                     71/80
  *plyU*       1872              YP_712780           KS-AT-DH-KR-ACP                                   Frankia alni ACN14a                     69/79
  *plyV*       2199              YP_712781           KS-AT-DH-ER-KR-ACP                                Frankia alni ACN14a                     70/78
  *plyW*       1041              YP_712782           KS-AT-ACP                                         Frankia alni ACN14a                     72/82
  *plyX*       1080              YP_712783           C-A-PCP                                           Frankia alni ACN14a                     62/72
  *plyY*       253               ZP_04472110         TE                                                Streptosporangium roseum DSM 43021      70/78
  *plyZ*       79                YP_001612061        LysR family transcriptional regulator             Sorangium cellulosum                    65/77
  *orf11*      287               YP_702564           Hypothetical protein                              Rhodococcus jostii RHA1                 56/73
  *orf14742*   170               YP_002777514        Hypothetical protein ROP_03220                    Rhodococcus opacus B4                   51/63

^a^Numbers are in amino acids.

Upstream of the *ply* gene cluster, three genes, *orf03394* (*orf1*), *orf03396* and *orf03399*, encoding proteins with similarities to 3-dehydroquinate synthase, sugar kinase and nucleotidyl transferase respectively, seemingly have no relationship with the biosynthesis of PLYA. *orf03392* (*orf2*), adjacent to *orf1*, is predicted to encode a protein with similarity to a transcriptional regulator, which may be involved in the biosynthesis of PLYs*.* Downstream of the *ply* gene cluster, three genes, *orf14746* (*plyZ*), *orf14744* (*orf11*) and *orf14742* encode proteins with similarities to LysR family transcriptional regulator, hypothetical protein ROP_29250 and hypothetical protein ROP_03220. To prove that the genes beyond this cluster are not related to PLY biosynthesis, we inactivated *orf1* and *orf11*. The resulting mutants have no effect on the PLYA production (Figure  [3](#F3){ref-type="fig"}, trace ii and iii), indicating that the 37 ORFs-contained *ply* gene cluster is responsible for the PLYs biosynthesis.

Assembly of the C~15~ acyl side chain by PKSs
---------------------------------------------

Within the *ply* cluster, 4 modular type I PKS genes (*plyTUVW*) encode four PKS modules, the organization of which is accordant with the assembly of the C~15~ acyl side chain of PLYA via three steps of elongation from the propionate starter unit (Figure  [2](#F2){ref-type="fig"}B). Both PlyT and PlyW consist of ketosynthase (KS), acyltransferase (AT), and acyl carrier protein (ACP). However, the active site Cys (for transthioesterification) of the PlyT-KS is replaced with Gln (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1), so it belongs to the so called "KS~Q~" that often occurs in the loading module of PKS system \[[@B24]\]. Therefore, PlyT acts as a loading module for formation of the propionate starter unit by catalyzing decarboxylation of methylmalonyl group after tethering onto ACP (Figure  [2](#F2){ref-type="fig"}B). The conserved regions of AT domain including the active site motif GHSQG \[[@B25]\] in both PlyT and PlyW (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S2), along with substrate specificity code (YASH) \[[@B26]\] indicate that both ATs are specific for methylmalonyl-CoA, consistent with the structure of the side chain of PLYA (Figure  [2](#F2){ref-type="fig"}B). In PlyU, in addition to KS, AT, and ACP domains, a dehydratase (DH) domain and a ketoreductase (KR) domain are present. However, the DH domain here is believed to be nonfunctional because the key amino acid residue H of the conserved motif HxxxGxxxxP \[[@B27]\] is replaced by Gln (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S3). The conserved motif of PlyU-AT for substrate selectivity is VPGH, neither including the serine residue in YASH for methylmalonyl-CoA nor phenylalanine residue in HAFH for malonyl-CoA (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S2). These changes may broaden the substrate binding pocket and enhance hydrophobicity of the substrate binding pocket, supporting that PlyU is able to recognize 2-(2-methylbutyl)malonyl 3 as an unusual extender unit (Figure  [2](#F2){ref-type="fig"}C). Compared to PlyU, PlyV contains an active DH domain and an enoyl reductase (ER) domain. The conserved motif (HAFH) of PlyV-AT signifies it specific for malonyl-CoA as the extender unit (Figure  [2](#F2){ref-type="fig"}B and Additional file [1](#S1){ref-type="supplementary-material"}: Figure S2). Taken together, PlyTUVW seem to be sufficient for the assembly of the C~15~ acyl side chain of PLYA.

Biosynthesis of 2-(2-methylbutyl)malonyl extender unit 3
--------------------------------------------------------

The structural analysis of PLYs and PKS architecture suggest that an unusual PKS extender unit 2-(2-methylbutyl)malonyl-CoA (or ACP, **3**) is required for the assembly of the C~15~ acyl side chain of PLYs. The biosynthesis of the 2-(2-methylbutyl)malonyl-CoA (or ACP) extender unit **3** would involve a reductive carboxylation mediated by a crotonyl-CoA reductase/carboxylase (CCR) homolog. Similar reactions have been reported for formation of ethylmalony-CoA \[[@B28],[@B29]\], 2-(2-chloroethyl)malonyl-CoA \[[@B30]\], and hexylmalonyl-CoA \[[@B31]\], as well as proposed for involvement of biosynthesis of cinnabaramides \[[@B32]\], thuggacins \[[@B33]\], sanglifehrins \[[@B34]\], germicidins and divergolides \[[@B35]\], ansalactams \[[@B36]\] and many other natural products. Analysis of the *ply* cluster reveals *orf5* encoding a CCR TgaD homolog (identity/similarity, 46%/59%) that was proposed to be involved in the biosynthesis of hexylmalonyl-CoA, an extender unit for the assembly of thuggacin \[[@B33]\]. *orf6*, adjacent to *orf5*, encodes a protein shared 71% identity and 81% similarity with 3-oxoacyl-ACP synthase III from *S. roseosporus* NRRL 15998. The gene *orf7*, located upstream of *orf6*, encodes an ACP that contains a catalytic motif DLDLDSL (the Serine is for phosphopantethein modification) \[[@B24]\]. The presence of these two genes indicates that the extender unit 2-(2-methylbutyl)malonyl may be tethered to ACP, not to CoA. In study of the biosynthesis of isobutylmalonyl-CoA extender unit for germicidins and divergolides, CCR, KSIII and HBDH (a 3-hydroxybutyryl-CoA hydrogenase) are transcribed in the same operon \[[@B35]\]. *orf567* and other three genes *orf8910* also constitute an operon (Figure  [2](#F2){ref-type="fig"}A). The genes *orf8910* encode α-keto acid dehydrogenase E2 component, E1 component β and α subunits, respectively, suggesting their involvement of the biosynthesis of **3** by reduction of the β-keto group (Figure  [2](#F2){ref-type="fig"}C). Given that the previous feeding study with isotope-labeled precursor suggested this 2-(2-methylbutyl)malonyl unit derived from isoleucine via a transamination \[[@B18]\], we proposed that an aminotransferase is required for the formation of α-keto acid, as shown in Figure  [2](#F2){ref-type="fig"}C. *plyN* is the only identified aminotransferase gene, so we constructed the Δ*plyN* mutant by replacement of the *plyN* gene with the *aac(3)IV-oriT* cassette (Additional file [1](#S1){ref-type="supplementary-material"}: Scheme S2). However, Δ*plyN* was found no effect on the PLYA production (Figure  [4](#F4){ref-type="fig"}, trace viii), so we assume that other aminotransferases may mediate this transamination for the incorporation of C~5~ unit of isoleucine into 3 (Figure  [2](#F2){ref-type="fig"}C).

![**Characterization of the discrete NRPS domains and aminotransferase in vivo.** LC-MS analysis (extracted ion chromatograms of m/z \[M + H\]^+^ 969.5 corresponding to PLYA) of *Streptomyces* sp. MK498-98F14 wild type (WT) and mutants (Δ*plyC*, Δ*plyD*, Δ*plyQ*, Δ*plyI,* Δ*plyS*, Δ*plyY* and Δ*plyN*).](1471-2180-14-30-4){#F4}

Assembly of the cyclodepsipeptide by NRPSs
------------------------------------------

After the C~15~ acyl side chain is assembled by 4 modular PKSs, it is transferred to 3-hydroxyleucine via an amide bond formation catalyzed by a NRPS, thus initiating the assembly of the peptide core. Within the biosynthetic gene cluster, there are 4 genes *plyFGHX* encoding modular NRPS proteins. Both PlyF and PlyG consist of two modules with seven domains (C-A1-PCP-E-C-A2-PCP) (Figure  [2](#F2){ref-type="fig"}B). Active epimerase (E) domains are present indicating that the amino acids activated by PlyF-A1 and PlyG-A1 should be converted into [d]{.smallcaps}-configuration. Among the six nonproteinogenic amino acid residues, only two piperazic acid residues are [d]{.smallcaps}-configuration, so these two A domains (PlyF-A1 and PlyG-A1) are proposed to recognize and activate [l]{.smallcaps}-piperazic acid (**4**, Figure  [2](#F2){ref-type="fig"}D) that was confirmed to be derived from [l]{.smallcaps}-ornithine \[[@B37]\]. This assumption can be supported by the findings that PlyF-A1 shares 52-59% identity and 64-69% similarity to PlyG-A1, KtzH-A1 \[[@B38]\], and HmtL-A1 \[[@B39]\] (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S4), and as well as the substrate specificity-conferring ten amino acids (DVFSVASYAK for PlyF-A1 and DVFSIAAYAK for PlyG-A1) are highly analogous to those of KtzH-A1 (DVFSVGPYAK) and HmtL-A1 (DVFSVAAYAK) \[[@B40],[@B41]\]. Both KtzH-A1 and HmtL-A1 were proposed to recognize and activate [l]{.smallcaps}-piperazic acid \[[@B38],[@B39]\]. PlyH contains five domains (C-A-M-PCP-TE) with a thioesterase (TE) domain present, indicating that PlyH is the last module of PLY NRPS system and responsible for the release and cyclization of the peptide chain via an ester bond formation. It is striking that an active methyltransferase (M) domain (containing the SAM-binding sites EXGXGXG) is present in the PlyH \[[@B42]\], but no N-methyl group is present in the structure of PLYs. The presence of this M domain remains enigmatic. Based on the PLY structure analysis and NRPS machinery \[[@B43]\], PlyH-A is proposed to recognize N-hydroxyvaline (**5**, Figure  [2](#F2){ref-type="fig"}E) as its substrate, but not valine because its substrate specificity-conferring codon sequences (DAPFEALVEX) are significantly distinct from those found for valine-specificity (DALWMGGTFK) \[[@B44]\]. Subsequently, the whole sequence of PlyH-A shows 76% identity and 83% similarity to that of PlyF-A2, indicating that PlyF-A2 is specific for N-hydroxyalanine (**6**, Figure  [2](#F2){ref-type="fig"}E and Additional file [1](#S1){ref-type="supplementary-material"}: Figure S5). These assignments are consistent with the amino acid sequence of the peptide core of PLYs. Finally, according to the collinearity of the NRPS modules and the building blocks of the NRPS-derived products, PlyG-A2 and PlyX would be proposed to recognize and activate (*R*)-3-hydroxy-3-methylproline (**7**, Figure  [2](#F2){ref-type="fig"}F) and 3-hydroxyleucine (**8**, Figure  [2](#F2){ref-type="fig"}G), respectively, although we can't predict their substrates based on their substrate specificity codons (Additional file [1](#S1){ref-type="supplementary-material"}: Table S4). Taken together, six NRPS modules activate six non-natural amino acids, and the substrate recognized by each domain is exactly consistent with the structure of the cyclic depsipeptide of PLYs (Figure  [2](#F2){ref-type="fig"}B).

Biosynthesis of nonproteinogenic amino acid building blocks
-----------------------------------------------------------

Except for the modular NRPSs, there are six discrete NRPS genes present in the *ply* gene cluster (Table  [1](#T1){ref-type="table"} and Figure  [2](#F2){ref-type="fig"}A), identified as an A domain (PlyC), two PCP domains (PlyD, PlyQ) and three TE domains (PlyI, PlyS, PlyY). To test whether these six free-standing domains were involved in the biosynthesis of PLYA, we constructed their disruption mutants by gene replacement with the *aac(3)IV-oriT* cassette (Additional file [1](#S1){ref-type="supplementary-material"}: Scheme S3-8). The mutant strains (Δ*plyC*, Δ*plyD*, Δ*plyQ*, Δ*plyI* and Δ*plyS*) completely abolished the production of PLYA (Figure  [4](#F4){ref-type="fig"}, traces i-v), indicating that these 5 discrete NRPS domains are essential for the PLYA biosynthesis. However, the Δ*plyY* mutant strain still produced PLYA, but the productivity decreased in comparison with that of the wild type strain (Figure  [4](#F4){ref-type="fig"}, trace vi and vii). Therefore, PlyY may act as a type II TE, probably playing an editing role in the biosynthesis of PLYA by hydrolyzing misincorporated building blocks. Multiple sequence alignment reveals that PlyY and typical type II TEs contain a conserved motif (GHSXG) and catalytic triad S/C-D-H that is consistent with hydrolytic function (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S6) \[[@B45]-[@B47]\]. This catalytic triad is also present in PlyI and PlyS, indicating the hydrolytic function of PlyI and PlyS, as shown by Figure  [2](#F2){ref-type="fig"}E and G.

The discrete NRPS domains have been found in many NRPS assembly lines responsible for the formation of nonproteinogenic building blocks \[[@B21],[@B48]\]. For example, the conversion of proline to pyrrole-2-carboxylic acid, which is a precursor for the biosynthesis of pyoluteorin, prodigiosin, and clorobiocin \[[@B49]\], occurs while proline is activated by a discrete A domain and covalently tethered in a thioester linkage to a T domain. Since all the A domains of six modular NRPSs in the PLY biosynthetic pathway are proposed to recognize and activate nonproteinogenic amino acid building blocks, PlyCDQIS are assumed to be responsible for the formation of several monomers of PLYs from the natural amino acids. Given that we can't predict the substrate based on the key residues of the substrate-binding pocket of PlyC (A domain), we propose that PlyC may activate multiple amino acids such as alanine and valine or leucine, and tether them to the corresponding PCPs (PlyD and PlyQ). After N-hydroxylation of alanine and valine (Figure  [2](#F2){ref-type="fig"}E) as well as β-hydroxylation of leucine (Figure  [2](#F2){ref-type="fig"}G), the matured building blocks are proposed to be released by discrete TEs (PlyI or PlyS, respectively) and activated again by PlyF-A2, PlyH, and PlyX, respectively (Figure  [2](#F2){ref-type="fig"}B). Such processes are rare events in typical NRPS-driven biosynthetic pathways \[[@B21]\].

The depsipeptide core of PLYA is composed of 6 amino acids, 5 of which are hydroxylated. There are 6 genes encoding putative hydroxylases or oxygenases. For example, *plyR* encodes a cytochrome P450 monooxygenase that shows high homology (37% identity and 54% similarity) to NikQ that was demonstrated to catalyze β-hydroxylation of histidine tethered to PCP, so we could propose that PlyR may be involved in the formation of β-hydroxyleucine building block (Figure  [2](#F2){ref-type="fig"}G). Indeed, inactivation of *plyR* resulted in loss of ability to produce PLYA (Figure  [5](#F5){ref-type="fig"}A, trace i). Given that FAD-dependent monooxygenase CchB has been reported to catalyze the N-hydroxylation of the δ-amino group of ornithine in the biosynthetic pathway of the siderophore coelichelin \[[@B50]\], we proposed that PlyE, a FAD-dependent monooxygenase, may be responsible for N-hydroxylation of alanine and valine when they are activated and tethered to a PCP by A domain PlyC (Figure  [2](#F2){ref-type="fig"}E). The Δ*plyE* mutant lost ability to produce PLYA (Figure  [5](#F5){ref-type="fig"}A, trace ii), indicating its possible role in formation of N-hydroxyalanine and N-hydroxyvaline. PlyP, a [l]{.smallcaps}-proline 3-hydroxylase, should be responsible for hydroxylation of 3-methyl-[l]{.smallcaps}-proline that is biosynthesized from [l]{.smallcaps}-isoleucine demonstrated by isotope-feeding study (Figure  [2](#F2){ref-type="fig"}F) \[[@B18]\]. Inactivation of *plyP* indeed abolished the production of PLYA (Figure  [5](#F5){ref-type="fig"}A, trace iii). Recently, Tang and co-workers have reported that an α-ketoglutarate dependent dioxygenase EcdK catalyzes a sequential oxidations of leucine to form the immediate precursor of 4-methylproline \[[@B51]\]. In the *ply* cluster, the only gene *plyO* encodes an α-ketoglutarate dependent dioxygenase, but it doesn't share any homology to EcdK. In contrast, PlyO shows 48% identity and 64% similarity to phytanoyl-CoA dioxygenase (YP_003381511 from *Kribbella flavida* DSM 17836). It remains unclear whether PlyO may be responsible for the hydroxylation of the carbon adjacent to the acyl group of the C~15~ acyl side chain or for the formation of 3-methyl-[l]{.smallcaps}-proline from [l]{.smallcaps}-isoleucine. *orf4* encodes a FAD-binding oxygenase or hydroxylase with high homology to type II PKS-assembled aromatic compounds hydroxylase (Table  [1](#T1){ref-type="table"}). Its role in biosynthesis of PLYA remains unclear, but it might be involved in the biosynthesis of a building block because its inactivation abolished the PLY production (Figure  [5](#F5){ref-type="fig"}A, trace iv).

![**Characterization of the genes encoding hydroxylases or oxygenases. A**, LC-MS analysis (extracted ion chromatograms of m/z \[M + H\]^+^ 969.5 corresponding to PLYA) of *Streptomyces* sp. MK498-98F14 wild type (WT) and mutants (Δ*plyE*, Δ*plyP*, Δ*plyR*, Δ*orf4*, and Δ*plyM*). **B**, LC-MS analysis (extracted ion chromatograms of m/z \[M + Na\]^+^ 975.5 and 991.5 corresponding to PLYB and PLYA) of *Streptomyces* sp. MK498-98F14 wild type (WT) and the Δ*plyM* mutant. **C**, LC-MS analysis (extracted ion chromatograms of m/z \[M + Na\]^+^ 959.5 corresponding to the putative biosynthetic intermediate of PLYA lacking two hydroxyl groups) of *Streptomyces* sp. MK498-98F14 wild type (WT) and mutants (Δ*plyE*, Δ*plyP*, Δ*plyR* and Δ*plyM*). **B** was performed under the conditions: 35-95% B (linear gradient, 0--20 min), 100% B (21--25 min), 35% B (25-40 min) at the flow rate of 0.3 mL/min.](1471-2180-14-30-5){#F5}

Piperazic acid is an attractive building block of many complex secondary metabolites such as Antrimycin \[[@B52]\], Chloptosin \[[@B53]\], Himastatin \[[@B39]\], Luzopeptin \[[@B54]\], Quinoxapeptin \[[@B55]\], Lydiamycin \[[@B56]\], Piperazimycin \[[@B57]\] and Sanglifehrin \[[@B58]\]. The detailed biosynthetic mechanisms by which piperazic acid are formed are not well understood. Recently, Walsh and coworkers demonstrated that KtzI, a homolog of lysine and ornithine N-hydroxylases catalyzes the conversion of ornithine into piperazic acid in kutzneride biosynthetic pathway \[[@B37]\]. No such a homolog was found in the *ply* gene cluster, but two putative homologs are located outside the *ply* gene cluster (Orf11257 and Orf14738), suggesting that the biosynthesis of piperazic acid may follow the same pathway (Figure  [2](#F2){ref-type="fig"}D).

Genes putatively for post-modifications
---------------------------------------

Most modifications in PLYA biosynthesis take place for the formation of the non-natural building blocks. Recently, Ju and co-workers demonstrated that a cytochrome P450 monooxygenase HtmN catalyzes the hydroxylation of the piperazic acid after peptide formation \[[@B59]\]. There are two cytochrome P450 monooxygenase genes (*plyM* and *plyR*) in the *ply* cluster. PlyR was proposed to hydroxylate leucine that is tethered to a PCP, so we would assume that PlyM may catalyze the hydroxylation of piperazic acid unit as a post-modification although it doesn't show any homology to HmtN \[[@B39]\]. To test this hypothesis, we constructed the double-crossover mutant by replacement of *plyM* with the *aac(3)IV-oriT* gene cassette that is not producing PLYA (Figure  [5](#F5){ref-type="fig"}A, trace v), only accumulating PLYB (Figure  [5](#F5){ref-type="fig"}B). These findings indicate that PlyM is responsible for the conversion of PLYB into PLYA (Figure  [2](#F2){ref-type="fig"}B). To test whether other oxygenases or hydroxylases are involved in the post-modifications, the mass corresponding to the putative intermediate of PLYA lacking two hydroxyl groups was monitored for the mutant strains (Figure  [5](#F5){ref-type="fig"}C). This mass is only detected from the fermentation broth of wide type and Δ*plyM* strains (Figure  [5](#F5){ref-type="fig"}C, trace v and iv), not from other mutant strains (Δ*plyE*, Δ*plyP* and *ΔplyR*) indicating that the assembly of PLYA and possible intermediates is abolished. These data may support that these genes are involved in the formation of building blocks, not post-modifications. They also indicate that it is very likely to have two steps of post-hydroxylation modifications for maturation of PLYA (Figure  [2](#F2){ref-type="fig"}B). When and how the hydroxylation at the α-carbon of the C~15~ acyl side chain takes place are still unclear.

Conclusions
===========

We identified and characterized the *ply* gene cluster composed of 37 open reading frames (ORFs) by genomic sequencing and systematic gene disruptions. The biosynthetic pathway has been proposed based on bioinformatics analysis, the structural analysis of PLYs and genetic data. It was demonstrated that five discrete NRPS domains are essential for the biosynthesis of PLYs and proposed their roles in maturation of three unusual amino acid building blocks. The proposed biosynthetic pathway for PLYs will open the door to understand the biosynthesis of this family of secondary metabolites and set a stage to explore combinatorial biosynthesis to create new compounds with improved pharmaceutical properties.
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Methods
=======

Strains, plasmids, primers and culture conditions
-------------------------------------------------

Strains, plasmids and primers used in the study are summarized in Additional file [1](#S1){ref-type="supplementary-material"}: Tables S1, S2 and S3 of the supplemental material. *Escherichia coli* strains were cultured on Luria-Bertani (LB) broth and agar medium at 37°C. *Streptomyces* sp. MK498-98 F14 and its mutant strains were cultivated at 30°C on the medium (yeast extract 0.4%, glucose 0.4%, malt extract 1%, agar 1.2%, pH 7.2) for sporulation and on 2CM \[[@B60]\] medium (soluble starch 1%, tryptone 0.2%, NaCl 0.1%, (NH~4~)~2~SO~4~ 0.2%, K~2~HPO~4~ 0.1%, MgSO~4~ 0.1%, CaCO~3~ 0.2%, agar 1.2% with 1 mL inorganic salt solution per liter, pH7.2) for conjugation. For fermentation, mycelia of strain MK498-98 F14 and its mutants from the solid plates were inoculated into a 500-mL Erlenmeyer flask containing 100 mL of a medium composed of glucose 1%, potato starch 1%, glycerol 1%, polypepton 0.5%, meat extract 0.5%, sodium chloride 0.5%, and calcium carbonate 0.32% (adjusted to pH 7.4) \[[@B2]\]. The culture was incubated at 28°C for six days on a rotatory shaker at 220 rpm.

General genetic manipulations and reagents
------------------------------------------

The general genetic manipulation in *E. coli* and *Streptomyces* were carried out following the standard protocols \[[@B22]\]. PCR amplifications were performed on a Veriti thermal cycler (Applied Biosystems, Carlsbad, CA) using Taq DNA polymerase. DNA fragments and PCR products were purified from agarose gels using a DNA Gel Extraction Kit (Omega). Primers were synthesized in Sangong Biotech Co. Ltd. Company (Shanghai, China). All DNA sequencing was accomplished at Shanghai Majorbio Biotech Co. Ltd (Shanghai, China). Restriction enzymes were purchased from New England Biolabs (Ipswich, MA) and Fermentas (St. Leon-Rot, Germany). Taq DNA polymerase and DNA ligase were purchased from Takara Co. Ltd. Company (Dalian, China).

Genomic library construction and screening
------------------------------------------

A genomic cosmid library of *Streptomyces* sp. MK498-98 F14 derived from SuperCos1 was constructed according to the procedure as described by the SuperCos1 Cosmid Vector Kit. *E. coli* EPI300™-T1^R^, instead of *E.coli* XL1-Blue MR, was used as the host strain. The total number of recombinant clones was about 3000 and then stored at −70°C. Two pairs of primers for two hydroxylase genes, *orf0337*4 (*plyE*) and *orf14777* (*plyP*) were designed and used to screen the genomic cosmid library by PCR.

Genome sequencing and analysis
------------------------------

Genome sequencing was accomplished by 454 sequencing technology. Open reading frames were analyzed using the Frame Plot 3.0 beta online \[[@B61]\], and the analysis of the deduced function of the proteins were carried out by the NCBI website \[[@B62]\]. Primer design, multiple nucleotide sequence alignments and analysis were performed using the BioEdit. The NRPS-PKS architecture was analyzed by NRPS-PKS online website (<http://nrps.igs.umaryland.edu/nrps/>) \[[@B63]\] and the prediction of ten amino acid of the conserved substrate-binding pocket of the A domain was performed using the online program NRPS predictor (<http://ab.inf.unituebingen.de/toolbox/index.php?view=domainpred>) \[[@B64]\].

Construction of gene inactivation mutants
-----------------------------------------

All the mutant strains in this study were generated by homologous recombination according to the standard method \[[@B65]\]. The target genes were replaced with an apramycin-resistance gene from pIJ773 on SuperCos1 by traditional PCR-targeting technique. Then the recombinant plasmids were transformed into *E. coli* S17-1 cells for conjugation. The exconjugants would appear three days later and could be transferred to a new growth medium supplemented with apramycin (60 μg/mL) and nalidixic acid (100 μg/mL). Double-crossover mutants were identified through diagnostic PCR with corresponding primers (Additional file [1](#S1){ref-type="supplementary-material"}: Table S3).

LC-MS analyses of wild type and mutant strains
----------------------------------------------

After finishing the fermentation, the culture broth of wild type and mutant strains were extracted by equal volume of ethyl acetate. The supernatant of the ethyl acetate phase was concentrated by rotary evaporator under the reduced pressure and finally dissolved in methanol (400 μL) for the LC-MS analysis using the Agilent 1100 series LC/MSD Trap system. The conditions for the LC-MS analysis are as follows: 55-100% B (linear gradient, 0--25 min, solvent A is water containing 0.1% formic acid, solvent B is acetonitrile containing 0.1% formic acid), 100% B (26--30 min) at the flow rate of 0.3 mL/min with a reverse-phase column ZORBAX SB-C18 (Agilent, 5 μm, 150 mm × 4.6 mm). Figure  [4](#F4){ref-type="fig"}B was recorded with the conditions: 35-95% B (linear gradient, 0--20 min), 100% B (21--25 min), 35%B (25--40 min) at the flow rate of 0.3 mL/min.

Nucleotide sequence accession number
------------------------------------

The sequence of the polyoxypeptin A biosynthetic gene cluster was deposited in GenBank with accession number KF386858.
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